Welcome
Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.
Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.
Follow us on Twitter to stay updated on news
Latest news
TWINFLAG meeting in Vigo, Spain (June, 2024)
TWINFLAG project partners from IMC, UCD, and Vigo University, along…
ASEICA 40th ANNIVERSARY CONGRESS – A Coruña, 2023
A Coruña become the center of cancer research from November…
“Francisco Guitián Ojea” Award I RAGC
July 2020 Galician Royal Academy of Sciences (RAGC) Awards Thanks to RAGC…
María Mayán at the Governing bodies of SEBBM
July 2020 New Boards of Directors at SEBBM The Governing…